The objective of this study was to evaluate whether electroporation could increase the efficacy of the bcl-2 ASO G3139 on mice bearing human melanoma in combination chemotherapy, in order to identify an innovative approach for antisense delivery to tumors and to increase the response of melanoma to therapy. Here, BCL2 is linked to melanoma.